CD14 expression and production by human hepatocytes

J Hepatol. 1999 Sep;31(3):435-42. doi: 10.1016/s0168-8278(99)80034-8.

Abstract

Background/aims: CD14 has been identified as a receptor for LPS and is present both in a membrane-bound and a soluble form. Membrane CD14 (mCD14) is predominantly expressed on monocytes, macrophages and granulocytes. The source of soluble CD14 (sCD14) is as yet unclear. Previous investigation using monocytes has shown that sCD14 can be derived either from the shedding of mCD14 or from direct secretion by monocytes. Whether the monocyte is the sole or even the major source of sCD14 is as yet uncertain. Clearance of LPS from the bloodstream is thought to be primarily mediated by the liver. Production of CD14 by hepatocytes would potentially provide a powerful mechanism by which the liver could clear LPS, and therefore we examined the ability of human hepatocytes to produce CD14.

Methods: Human hepatocytes were isolated using collagenase perfusion.

Results: Human hepatocytes were found to have CD14 mRNA by Northern blot analysis. Western blot analysis and immunohistochemical staining confirmed CD14 protein in primary hepatocyte cultures. Further studies showed that a liver epithelial-like cell line AKN-1 is capable of producing CD14. Comparisons of the size of hepatocyte-derived CD14 protein with the sCD14 protein from the human monocytic leukemia cell line HL60 suggested that a slightly larger form of CD14 is expressed by human liver cells.

Conclusion: This is the first study to demonstrate production of CD14 by human hepatocytes.

Publication types

  • Research Support, Non-U.S. Gov't
  • Research Support, U.S. Gov't, P.H.S.

MeSH terms

  • Cell Line
  • Epithelial Cells / immunology
  • Humans
  • Lipopolysaccharide Receptors / biosynthesis*
  • Lipopolysaccharides / blood
  • Liver / cytology
  • Liver / immunology*
  • Metabolic Clearance Rate
  • Solubility

Substances

  • Lipopolysaccharide Receptors
  • Lipopolysaccharides